Tag Archive | "ipsen"

Ipsen and Lexicon signs pharma licensing deal

Tags: , , , ,

Ipsen and Lexicon Pharmaceuticals have entered into an exclusive pharma licensing deal for Ipsen to commercialize telotristat etiprate outside of North America and Japan, with a focus on the treatment of carcinoid syndrome. Read the full story

Partnering Agreements with Ipsen

Tags: ,

The Partnering Agreements with Ipsen report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story

M&A Activity for Ipsen

Tags: , , ,

Ipsen merger and acquisition deals during 2009-2014 in pharmaceuticals reviewed. Read the full story

Ipsen: Partnering activity 2009-2014

Tags: , ,

Ipsen is a specialty pharmaceutical company listed as one of the top 50 bigbiotech companies by Current Partnering (listed by 2012 revenue). Read the full story

Ipsen: Developing niche products to increase life expectancy

Tags: , ,

Ipsen is a French specialty pharmaceutical company developing products to increase life expectancy. Read the full story

Ipsen biotech deals Harvard Medical School in collaborative R&D agreement

Tags: , ,

Ipsen initiates biotech deals for research and development collaboration on novel engineered botulinum toxins with Harvard Medical School. Read the full story

M&A news: Ipsen acquires Syntaxin for $206 million

Tags: , , ,

In M&A news, Ipsen announced the closing of the acquisition of Syntaxin, a UK-based private life sciences company specialized in botulinum toxin engineering. Read the full story